학술논문
Effects of Bypassing Hemostatic Agents in the Co-Presence of NXT007, EmicizumabBased Engineered Bispecific Antibody to Fixa/Fx, Using in Vitro Global Assays: Rough Indicators for Their Concomitant Use
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020